News Column

New Therapeutics and Clinical Risk Management Study Findings Recently Were Reported by Researchers at University of Gottingen (Ethical and legal...

August 15, 2014



New Therapeutics and Clinical Risk Management Study Findings Recently Were Reported by Researchers at University of Gottingen (Ethical and legal framework and regulation for off-label use: European perspective)

By a News Reporter-Staff News Editor at Health & Medicine Week -- Current study results on Health and Medicine have been published. According to news reporting originating from Gottingen, Germany, by NewsRx correspondents, research stated, "For more than 20 years the off-label use of drugs has been an essential part of the ethical and legal considerations regarding the international regulation of drug licensing. Despite a number of regulatory initiatives in the European Union, there seems to remain a largely unsatisfactory situation following a number of critical descriptions and statements from actors in the field."

Our news editors obtained a quote from the research from the University of Gottingen, "The present article gives an overview of the ethical and legal framework and developments in European countries and identifies existing problems and possible pathways for solutions in this important regulatory area. In addition to the presentation of the ethical and legal foundations, some attention is given to criticisms from medical practitioners to the current handling of off-label drug use. The review also focuses on the situation confronted by patients and physicians when off-label prescriptions are necessary."

According to the news editors, the research concluded: "Through legal descriptions from a number of countries, possible solutions for future discussion of European health care policy are selected and explained."

For more information on this research see: Ethical and legal framework and regulation for off-label use: European perspective. Therapeutics and Clinical Risk Management, 2014;10():537-546. Therapeutics and Clinical Risk Management can be contacted at: Dove Medical Press Ltd, PO Box 300-008, Albany, Auckland 0752, New Zealand (see also Health and Medicine).

The news editors report that additional information may be obtained by contacting C. Lenk, University of Gottingen, Center Med Law, D-37073 Gottingen, Germany.

Keywords for this news article include: Europe, Germany, Gottingen, Legal Issues, Health and Medicine

Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2014, NewsRx LLC


For more stories on investments and markets, please see HispanicBusiness' Finance Channel



Source: Health & Medicine Week


Story Tools






HispanicBusiness.com Facebook Linkedin Twitter RSS Feed Email Alerts & Newsletters